Scholar Rock Holding (SRRK) Amortizatization of Intangibles (2018 - 2026)
Scholar Rock Holding's quarterly Amortizatization of Intangibles came in at $1.5 million in Q1 2026, up 24.09% year-on-year from $1.2 million in Q1 2025, and up 11.19% quarter-over-quarter from $1.4 million in Q4 2025.
Scholar Rock Holding has reported Amortizatization of Intangibles for 9 years, with the latest figure at $1.5 million in Q1 2026.
- For the quarter ending Q1 2026, Amortizatization of Intangibles rose 24.09% year-over-year to $1.5 million; the trailing twelve-month figure through Mar 2026 stood at $5.6 million (up 20.55% YoY), and the FY2025 full-year result was $5.3 million, down 0.55% from the prior year.
- Amortizatization of Intangibles for Q1 2026 stood at $1.5 million, up from $1.4 million in the prior quarter.
- The five-year high for Amortizatization of Intangibles was $2.1 million in Q2 2025, with the low at $581000.0 in Q3 2025.
- Average Amortizatization of Intangibles over 5 years is $1.5 million, with a median of $1.7 million recorded in 2022.
- Year-over-year, Amortizatization of Intangibles surged 1715.45% in 2022 and sank 56.0% in 2023.
- Tracing SRRK's Amortizatization of Intangibles over 5 years: stood at $1.8 million in 2022, then climbed by 1.46% to $1.8 million in 2023, then declined by 25.35% to $1.3 million in 2024, then increased by 2.9% to $1.4 million in 2025, then increased by 11.19% to $1.5 million in 2026.
- The last three Amortizatization of Intangibles figures came in at $1.5 million (Q1 2026), $1.4 million (Q4 2025), and $581000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 13,267.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Scholar Rock Holding | 500.61 Mn | 20.67 Mn | - | 1.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.54 Mn |
| Mar 31, 2026 | 1.54 Mn |
| Dec 31, 2025 | 1.39 Mn |
| Dec 31, 2025 | 1.39 Mn |
| Sep 30, 2025 | 581,000.00 |
| Sep 30, 2025 | 581,000.00 |
| Jun 30, 2025 | 2.06 Mn |
| Jun 30, 2025 | 2.06 Mn |
| Mar 31, 2025 | 1.24 Mn |
| Mar 31, 2025 | 1.24 Mn |
| Dec 31, 2024 | 1.35 Mn |
| Dec 31, 2024 | 1.35 Mn |
| Sep 30, 2024 | 1.05 Mn |
| Sep 30, 2024 | 1.05 Mn |
| Jun 30, 2024 | 974,000.00 |
| Jun 30, 2024 | 974,000.00 |
| Mar 31, 2024 | 1.92 Mn |
| Mar 31, 2024 | 1.92 Mn |
| Dec 31, 2023 | 1.80 Mn |
| Dec 31, 2023 | 1.80 Mn |
| Sep 30, 2023 | 1.85 Mn |
| Sep 30, 2023 | 1.85 Mn |
| Jun 30, 2023 | 751,000.00 |
| Jun 30, 2023 | 751,000.00 |
| Mar 31, 2023 | 1.81 Mn |
| Mar 31, 2023 | 1.81 Mn |
| Dec 31, 2022 | 1.78 Mn |
| Dec 31, 2022 | 1.78 Mn |
| Sep 30, 2022 | 1.74 Mn |
| Sep 30, 2022 | 1.74 Mn |
| Jun 30, 2022 | 1.71 Mn |
| Jun 30, 2022 | 1.71 Mn |
| Mar 31, 2022 | 1.68 Mn |
| Mar 31, 2022 | 1.68 Mn |
| Dec 31, 2021 | -110,000.00 |
| Dec 31, 2021 | -110,000.00 |
| Sep 30, 2021 | -3.92 Mn |
| Sep 30, 2021 | -3.92 Mn |
| Jun 30, 2021 | 1.57 Mn |
| Jun 30, 2021 | 1.57 Mn |
| Mar 31, 2021 | 1.54 Mn |
| Mar 31, 2021 | 1.54 Mn |
| Dec 31, 2020 | 1.59 Mn |
| Dec 31, 2020 | 1.59 Mn |
| Sep 30, 2020 | 268,000.00 |
| Sep 30, 2020 | 268,000.00 |
| Jun 30, 2020 | 346,000.00 |
| Jun 30, 2020 | 346,000.00 |
| Mar 31, 2020 | 177,000.00 |
| Mar 31, 2020 | 177,000.00 |
| Dec 31, 2019 | 648,000.00 |
| Dec 31, 2019 | 648,000.00 |
| Sep 30, 2019 | 250,000.00 |
| Sep 30, 2019 | 250,000.00 |
| Jun 30, 2019 | 127,000.00 |
| Jun 30, 2019 | 127,000.00 |
| Mar 31, 2019 | 365,000.00 |
| Mar 31, 2019 | 365,000.00 |
| Mar 31, 2018 | 31,000.00 |
| Mar 31, 2018 | 31,000.00 |